Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 83301, Taiwan
NCT Number: NCT04989569
To explore whether serial changes of data in body composition of patients with sepsis can help clinician to monitor prognosis.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Kaohsiung City, 83301, Taiwan
The investigators will use the random number generator to divide the patients into two groups, the control group (with no nutritional intervention) and the intervention group (with nutritional intervention). The body composition data (of day 1, 3, 8) of the patients in the intervention group will be given to the dietitians for adjusting the diet formula according to the patient's body composition.The patients in control group also will undergo Bio-electrical Impedance Analysis (BIA) assessment, but not disclosed to the dietitian. The diet formula will be adjusted on the discretion of the dietitian caring for the septic patients based on clinical judgement.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the intervention group, the body composition data (of day 1, 3, 8) will be given to the dietitians for adjusting the diet formula. The diet formula will be adjusted on the discretion of the dietitian caring for the septic patients based on clinical judgement. The policy adopted by the dietary treatment guidelines for sepsis is to adjust the dietary concentration when there is too much extracellular water under the premise of gastrointestinal tolerance. When the skeletal muscle mass loss is too fast, the dietitians will increase the protein intake by 1.2g/kg of body weight. For patients with acute renal failure and excess extracellular water accumulation and muscle loss, the dietitians will adjust the protein, sodium, potassium, calcium and phosphorus content in the formula. The dietitians will give appropriate nutrition prescriptions based on clinical signs, disease diagnosis and biochemical values.
Time frame: The day discharged from ICU, an average of 2 weeks
Status of survival or mortality at the time discharged from ICU
Time frame: The day discharged from hospital, an average of 5 weeks
Status of survival or mortality at the time discharged from hospital
Time frame: Day 7 after hospital admission
Status of survival or mortality at Day 7 during hospital stay
Time frame: Day 28 after hospital admission
Status of survival or mortality at Day 28 during hospital stay
Time frame: Day 90 after hospital admission
Status of survival or mortality at Day 90 during hospital stay
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of white blood cell count between day 1 and day 3
Time frame: Day 1 and Day8 after ICU admission
assessing the change of white blood cell count between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of white blood cell count between day 3 and day 8
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of pulse pressure between day 1 and day 3
Time frame: Day 1 and Day 8 after ICU admission
assessing the change of pulse pressure between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of pulse pressure between day 3 and day 8
Time frame: Day 1 after ICU admission
assessing Sequential Organ Failure Assessment score at day 1
Time frame: Day 3 after ICU admission
assessing Sequential Organ Failure Assessment score at day 3
Time frame: Day 8 after ICU admission
assessing Sequential Organ Failure Assessment score at day 8
Time frame: The day weaned off ventilator, an average of 3 weeks
Total using days of mechanical ventilation
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of percentage of body fat between day 1 and day 3
Time frame: Day 1 and Day 8 after ICU admission
assessing the change of percentage of body fat between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of percentage of body fat between day 3 and day 8
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of protein intake (g/day, g/kg) between day 1 and day 3
Time frame: Day 1 and Day 8 after ICU admission
assessing the change of protein intake (g/day, g/kg) between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of protein intake (g/day, g/kg) between day 3 and day 8
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of energy intake (total kcal/day) between day 1 and day 3
Time frame: Day 1 and Day 8 after ICU admission
assessing the change of energy intake (total kcal/day) between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of energy intake (total kcal/day) between day 3 and day 8
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of segment count to monocyte count ratio between day 1 and day 3
Time frame: Day 1 and Day 8 after ICU admission
assessing the change of segment count to monocyte count ratio between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of segment count to monocyte count ratio between day 3 and day 8
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of total body water between day 1 and day 3
Time frame: Day 1 and Day 8 after ICU admission
assessing the change of total body water between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of total body water between day 3 and day 8
Time frame: Day 1 and Day 3 after ICU admission
assessing the change of soft lean mass between day 1 and day 3
Time frame: Day 1 and Day 8 after ICU admission
assessing the change of soft lean mass between day 1 and day 8
Time frame: Day 3 and Day 8 after ICU admission
assessing the change of soft lean mass between day 3 and day 8
Time frame: The day discharged from ICU, an average of 2 weeks
length of ICU stay
Chang Gung Memorial Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06541600
Infections, Inflammation
Wuhan, Hubei, China
View Trial DetailsNCT06080282
Infections, Inflammation
Wuhan, Hubei, China
View Trial DetailsNCT07025096
Acute Respiratory Distress Syndrome (ARDS), Infections
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06876168
Acute Respiratory Failure, Infections
Lexington, Kentucky, United States
View Trial Details